News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
ESMO Presents Findings on ADC Target Expression in Ovarian Cancer at ESMO Gynae25
Photo: depositphotos.com
Jun 25, 2025, 07:04

ESMO Presents Findings on ADC Target Expression in Ovarian Cancer at ESMO Gynae25

ESMO – European Society for Medical Oncology posted on LinkedIn:

“ADCs present a promising therapeutic option, however the expression patterns of key ADC targets remain unclear.
This study presented at ESMO Gynae25 evaluated the expression of five ADC targets to assess their potential utility in Ovarian Cancer.
Findings reveal targetable alterations, that could lead to better therapeutic options and improved patient outcomes.”

ESMO Presents Findings on ADC Target Expression in Ovarian Cancer at ESMO Gynae25

Read Further: 20 Posts Not to Miss from ESMO Gynaecological Cancers Congress 2025.

ADC cancer ESMO ESMO Gynae25 OncoDaily Oncology Ovarian Cancer
Special Coverage
Insight
Aug 12, 2025, 11:29
Daniel Flora: Joining Ride Cincinnati 2025 for Cancer Research
Voices
Aug 12, 2025, 11:19
AACR President Highlights the Critical Value of Medical Research
Insight
Aug 12, 2025, 11:14
Felipe Couñago: URONCOR 06-24 Trial Data
Science
Aug 12, 2025, 11:04
Yüksel Ürün: CTCs are Cancer’s Messengers in the Blood Rare, but Powerful
Voices
Aug 12, 2025, 11:03
Amy C. Moore Wished Yvonne Diaz a Happy Birthday
Science
Aug 12, 2025, 10:50
Off-the-Shelf Cancer Vaccine Elicits Strong Immune Response in Patients with Pancreatic and Colorectal Cancer
Voices
Aug 12, 2025, 10:34
The Efficacy of Immune Checkpoint Inhibitors in Melanoma Through a Gut Microbiota - Mirrors of Medicine
Societies
Aug 12, 2025, 10:33
How Science, Technology, and Access are Coming Together to Stop Cancer Before it Starts - NFCR
Science
Aug 12, 2025, 10:24
Myeloma Paper of the Day, August 12th, Suggested by Robert Orlowski
New Paper Alert
Aug 12, 2025, 10:24
New Paper Alert: Older Age Threshold for Oxaliplatin Benefit in Stage II–III Colorectal Cancer Identified
Career Updates
Aug 12, 2025, 10:23
Bruce Cozadd: 22 Incredible Years Leading Jazz Pharmaceuticals
Insight
Aug 12, 2025, 10:23
Mario Balsa: The Impact of PAM50-based Prosigna in Neoadjuvant Planning for Early Breast Cancer